Fractional CO2 Laser Assisted Photodynamic Therapy

Last updated: July 29, 2015
Sponsor: Bispebjerg Hospital
Overall Status: Completed

Phase

2/3

Condition

Sun Poisoning

Squamous Cell Carcinoma

Basal Cell Carcinoma

Treatment

N/A

Clinical Study ID

NCT01260987
H-1-2010-044
2010-020179-22
  • Ages > 18
  • All Genders

Study Summary

Nodular Basal Cell Carcinomas:

Compare the efficacy and safety of conventional versus fractional laser assisted PDT for difficult to treat nodular cell carcinomas in the face.

Actinic keratosis:

Compare the efficacy and safety of conventional versus fractional laser assisted PDT for moderate to severe actinic keratoses located in the face and on the hands.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age 18 or older

  • Skin type I-III

  • Fertile women using secure birth control

  • Moderate to severe actinic keratoses in the face or on the hands,

  • Difficult to treat nodular basal cell carcinomas in the face

Exclusion

Exclusion Criteria:

  • Pregnancy or breast feeding patients

  • Patients with porphyria

  • Patients with Gorlins syndrome

  • Patients with a tendency to produce hypertrophic scars or keloids

  • Patients with known allergy to Metvix

  • Patients who are not considered able to follow the treatment protocol (e.g. severelyalcoholic, dementia, mentally ill etc.)

  • Patients with pigmented or morphea basal cell carcinomas

  • Know herpes simplex virus infection in treatment areas

Study Design

Total Participants: 47
Study Start date:
October 01, 2010
Estimated Completion Date:
August 31, 2012

Connect with a study center

  • Department of Dermatology, Bispebjerg Hospital

    Copenhagen, DK-2400
    Denmark

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.